Improving Brain Cancer Surgery

For this tumour, surgery is the first step. Surgeons during brain cancer surgery walk the tight rope of removing enough tumour without damaging the brain. Because brain cancer cells extend like thin tendrils several centimetres into the surrounding brain tissue. It is always a challenge for doctors to remove the entire tumour.  Brain cancer is highly recursive with almost 90% patients relapsing back within 6 to 7 months post-surgery (Even after being given chemotherapy and radiation postsurgery). More than 80% of the recurred cancer appears back where the surgery was done.  This is where patients usually lose the battle with this tumour. LeadInvent Pharma is developing modality that would complement the current standard of care for hard to treat tumours such as Glioblastoma.

Every child born with hypospadias / micropenis deserves best surgical outcome

1 in 200 children are born with a birth defect that leads to a condition called micropenis (an unusually small penis).  Some of these children are also born with a condition called hypospadias - a birth defect where the urinary opening is not at the usual location. Pediatric urologists have come up with many surgical techniques to fix this problem. However 6 % of children born with this indication carry a genetic defect due to which they do not respond to current standard of care. LeadInvent Pharma is working towards solving this problem so that every child is able to undergo corrective surgery.